Monday, 22 Jan 2018

You are here

RheumNow Week in Review – 26 August 2016

Dr. Jack Cush reviews news and journal reports from the past week on RheumNow.com.

  1. Japanese study 345 RA pts shows sustained high CRP levels associated with increased risk of CKD (~20%) https://t.co/VWOxuHOCDl
  2. Gout patients have a 17% increased risk of fracture (limbs & spine). Interestingly allopurinol use lowers risk http://buff.ly/2c1V2kI
  3. SPIRIT-P1 Study published in Lancet; Ixekizumab (Taltz), IL-17 inhibitor, better than Placebo, but same as Humira at 24wks in psoriatic arthritis outcomes; but Taltz superior to Humira at Psoriasis outcomes. https://t.co/mVZ0sMSHdX
  4. Hypotony (low intraocular pressure) is a sign of active, severe & usually symptomatic uveitis in Juvenile Arthritis https://t.co/qJOAWPcPpW
  5. RCT of osteoporotic vertebral fractures (< 6 wks) showed vertebroplasty twice better than placebo in reducing pain https://t.co/aIeKdXTU1C
  6. Risk factors for marginal ulcers in obesity gastric bypass surgery:Diabetes, Hx PUD, PPI & ASA use. But limited doses of. NSAIDs was not signif!cantly associated. PPI may be due to confounding by indication. https://t.co/9Ct4Xvmp2J
  7. DESIR early SpA Cohort - Structural progression is low (~5%) in early SpA; Sacroiliitis risk factors were B27, smoking & MRI SI inflammation https://t.co/MWsxlbb6lt
  8. Idiopathic Recurrent Pericarditis follows ~20% acute pericarditis; responds VERY well to IL-1 inhibition (anakinra) https://t.co/T28ggiTGyA
  9. Since FDA approval 2011, Benlystas uptake has been slow, but had $265 million in worldwide sales in 2014. https://t.co/hqViTE0PEs
  10. PsA have the same cancer & serious infx rates as non-PsA; but have more hematologic cancers & opportunistic infxns https://t.co/Mm9Ehpd19F
  11. Prior Cancer Patients May Safely Receive TNF Inhibitors or Rituximab
  12. Adalimumab Controls Non-Infectious Uveitis in VISUAL II Study
  13. Risk of Sepsis or Death Lower with Biologics in Rheumatoid Arthritis.
  14. EULAR 2016: Name that Country
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review - 19 January 2018

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report covers the rising cost of adalimumab, infections in myositis, phyisician burnout, biologics in Still's disease and weight loss benefits in RA. 

Rheumatology Physician Burnout and Depression

The 2018 Medscape Physician Burnout and Depression report shows that 42% of physician respondents report "burnout" and up to 15% experience some sort of depression. In a survey of 15,543 doctors from 29 specialties, they found highest burnout rates in critical care and neurologists (48%), family medicine (47%), ob/gyns and internists (46%). Lowest rates were seen in pathology and dermatology (32%), and plastic surgery (23%). 

What did rheumatologists report?

The RheumNow Week in Review - 12 January 2018

Dr. Jack Cush reviews a dozen highlights from the past week on RheumNow.com.

40% of Arthritis Patients Fail to Receive Exercise Guidance

The latest issue of CDC’s MMWR reports that exercise counseling among arthritis patients increased from 52% to 61% (2002 to 2014); hence ~40% do not receive health care provider counseling, suggesting the need for provider education and training in exercise counseling, and improved electronic medical record reminders.

The RheumNow Week in Review - 5 January 2018

Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com.